| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | S Muralidhar | |
| J Doniger | |||
| L J Rosenthal | |||
| P2860 | cites work | The regions of the retinoblastoma protein needed for binding to adenovirus E1A or SV40 large T antigen are common sites for mutations | Q24296000 |
| Wild-type p53 binds to the TATA-binding protein and represses transcription | Q24300991 | ||
| Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen | Q24308837 | ||
| Two distinct and frequently mutated regions of retinoblastoma protein are required for binding to SV40 T antigen | Q24337366 | ||
| Plaque-associated expression of human herpesvirus 6 in multiple sclerosis | Q24564496 | ||
| Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8) | Q24650427 | ||
| Basic local alignment search tool | Q25938991 | ||
| A simple method for displaying the hydropathic character of a protein | Q26778481 | ||
| Primary Characterization of a Herpesvirus Agent Associated with Kaposi’s Sarcoma | Q27636336 | ||
| The retinoblastoma protein and cell cycle control | Q27860722 | ||
| WAF1, a potential mediator of p53 tumor suppression | Q27861121 | ||
| A Chronic Illness Characterized by Fatigue, Neurologic and Immunologic Disorders, and Active Human Herpesvirus Type 6 Infection | Q28208561 | ||
| Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein | Q28238628 | ||
| Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma | Q28242984 | ||
| Induction of CD4 and susceptibility to HIV-1 infection in human CD8+ T lymphocytes by human herpesvirus 6 | Q28279600 | ||
| Identification of domains within the human cytomegalovirus major immediate-early 86-kilodalton protein and the retinoblastoma protein required for physical and functional interaction with each other. | Q39882060 | ||
| Cytomegalovirus in Semen: Observations in Selected Populations | Q39957658 | ||
| Herpesvirus Antibodies and Antigens in Patients With Cervical Anaplasia and in Controls 2 | Q39958117 | ||
| Oncogenic Transformation of Human Embryo Lung Cells by Human Cytomegalovirus | Q39991944 | ||
| Identification and characterization of a human herpesvirus 6 gene segment capable of transactivating the human immunodeficiency virus type 1 long terminal repeat in an Sp1 binding site-dependent manner. | Q40039602 | ||
| Transactivation by the human cytomegalovirus IE2 86-kilodalton protein requires a domain that binds to both the TATA box-binding protein and the retinoblastoma protein. | Q40041760 | ||
| The 86-kilodalton IE-2 protein of human cytomegalovirus is a sequence-specific DNA-binding protein that interacts directly with the negative autoregulatory response element located near the cap site of the IE-1/2 enhancer-promoter. | Q40043548 | ||
| Transcriptional activation of cellular oncogenes fos, jun, and myc by human cytomegalovirus. | Q40059647 | ||
| Inhibition of viral and cellular promoters by human wild-type p53 | Q40066650 | ||
| Venereal Causes of Cytomegalovirus Mononucleosis | Q40092847 | ||
| Evidence for the Association of Cytomegalovirus with Carcinoma of the Prostate | Q40107635 | ||
| Relation of Herpes Simplex Viruses to Human Malignancies | Q40111282 | ||
| Predominant CD4 T-lymphocyte tropism of human herpesvirus 6-related virus. | Q40116280 | ||
| Cytomegalovirus-leukocyte interactions | Q40142731 | ||
| HSV, CMV, and HPV in Human Neoplasia | Q40143077 | ||
| Association of Cytomegalovirus (CMV) Infection with Cervical Cancer: Isolation of CMV from Cell Cultures Derived from Cervical Biopsy | Q40159686 | ||
| Antibody patterns to herpesviruses in Kaposi's sarcoma. II. Serological association of american Kaposi's sarcoma with cytomegalovirus | Q40178496 | ||
| Transformation of hamster embryonic fibroblast cells by UV-irradiated human cytomegalovirus | Q40249217 | ||
| Cytomegalovirus Isolations from Cell Cultures of Human Adenocarcmomas of the Colon | Q40289274 | ||
| The retinoblastoma tumor suppressor protein. | Q40605932 | ||
| Herpesvirus particles in prostatic carcinoma cells | Q40638128 | ||
| The tumor suppressor genes | Q40856821 | ||
| Cytomegalovirus infection in previously healthy adults | Q40910267 | ||
| Human cytomegalovirus infection results in altered Cdk2 subcellular localization | Q41097052 | ||
| Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection. | Q41198290 | ||
| Targeted integration of human herpesvirus 6 in the p arm of chromosome 17 of human peripheral blood mononuclear cells in vivo | Q41332093 | ||
| RB kinases and RB-binding proteins: new points of view | Q41341093 | ||
| Retinoblastoma protein in growth suppression and death protection | Q41345444 | ||
| Modulatory effects of human cytomegalovirus infection on malignant properties of cancer cells | Q41392813 | ||
| Human herpesvirus 6 (HHV-6) is a helper virus for adeno-associated virus type 2 (AAV-2) and the AAV-2 rep gene homologue in HHV-6 can mediate AAV-2 DNA replication and regulate gene expression | Q41436909 | ||
| Transcriptional activation of minimal HIV-1 promoter by ORF-1 protein expressed from the SalI-L fragment of human herpesvirus 6. | Q41467843 | ||
| trans-activation of the HIV promoter by a cDNA and its genomic clones of human herpesvirus-6. | Q41483343 | ||
| Alteration in the coding potential and expression of H-ras in human cytomegalovirus-transformed cells | Q41495789 | ||
| E6-AP directs the HPV E6-dependent inactivation of p53 and is representative of a family of structurally and functionally related proteins. | Q41506160 | ||
| Detection of human herpesvirus 6 in tissues involved by sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). | Q41612403 | ||
| Activation of cellular oncogenes by clinical isolates and laboratory strains of human cytomegalovirus | Q41672267 | ||
| Isolation of human herpesvirus-6 (HHV-6) from patients with collagen vascular diseases | Q41686769 | ||
| Functional analysis of human cytomegalovirus morphological transforming region II (mtrll) | Q41693515 | ||
| Activation of Proto-Oncogenes: an Immediate Early Event in Human Cytomegalovirus Infection | Q41744434 | ||
| Lack of association of cytomegalovirus with adenocarcinoma of the colon | Q41881449 | ||
| A 79 amino acid oncogene is responsible for human cytomegalovirus mtrII induced malignant transformation | Q42596587 | ||
| Identification of homologues to the human cytomegalovirus US22 gene family in human herpesvirus 6 | Q42599565 | ||
| Identification of two promoters within human cytomegalovirus morphologic transforming region II. | Q42600922 | ||
| Localization and sequence analysis of morphological transforming region III within human cytomegalovirus strain Towne | Q42604143 | ||
| An immediate early gene of human cytomegalovirus encodes a potential membrane glycoprotein | Q42649036 | ||
| A transforming fragment within the direct repeat region of human herpesvirus type 6 that transactivates HIV-1. | Q42800173 | ||
| Human herpesvirus 6 (HHV-6) ORF-1 transactivating gene exhibits malignant transforming activity and its protein binds to p53. | Q42804539 | ||
| Growth regulation of a cellular tumour antigen, p53, in nontransformed cells | Q42819146 | ||
| Three cases of human herpesvirus-6 latent infection: integration of viral genome in peripheral blood mononuclear cell DNA. | Q43450985 | ||
| Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders | Q28282589 | ||
| KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma | Q28284765 | ||
| HBLV (or HHV-6) in human cell lines | Q28302015 | ||
| p53 mutations in human cancers | Q28302973 | ||
| Tumor suppressor p53 is a direct transcriptional activator of the human bax gene | Q28306186 | ||
| Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway | Q28776004 | ||
| A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia | Q29615437 | ||
| A workbench for multiple alignment construction and analysis | Q29618211 | ||
| mdm2 expression is induced by wild type p53 activity | Q29618316 | ||
| The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product | Q29618372 | ||
| E2F: a link between the Rb tumor suppressor protein and viral oncoproteins | Q29618375 | ||
| Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms | Q29618586 | ||
| p53 is required for radiation-induced apoptosis in mouse thymocytes | Q29620281 | ||
| Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product | Q29620421 | ||
| Analysis of a protein-binding domain of p53 | Q33292314 | ||
| Human herpes virus-6 increases HIV-1 expression in co-infected T cells via nuclear factors binding to the HIV-1 enhancer | Q33581303 | ||
| Localization and DNA sequence analysis of the transforming domain (mtrII) of human cytomegalovirus | Q33637054 | ||
| Multiple transforming regions of human cytomegalovirus DNA. | Q33928670 | ||
| Lipoproteins in bacteria | Q34660581 | ||
| The PROSITE dictionary of sites and patterns in proteins, its current status | Q34990619 | ||
| Human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) DNA in Kaposi's sarcoma lesions, AIDS Kaposi's sarcoma cell lines, endothelial Kaposi's sarcoma simulators, and the skin of immunosuppressed patients. | Q35774050 | ||
| High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis | Q35811381 | ||
| Cytomegalovirus infection induces high levels of cyclins, phosphorylated Rb, and p53, leading to cell cycle arrest | Q35849687 | ||
| Human cytomegalovirus mtrII oncoprotein binds to p53 and down-regulates p53-activated transcription | Q35873729 | ||
| Human cytomegalovirus IE2 86-kilodalton protein binds p53 but does not abrogate G1 checkpoint function. | Q35889716 | ||
| PROSITE: a dictionary of sites and patterns in proteins | Q35921056 | ||
| An in vitro system for human cytomegalovirus immediate early 2 protein (IE2)-mediated site-dependent repression of transcription and direct binding of IE2 to the major immediate early promoter | Q36069170 | ||
| Human cytomagalovirus IE1 and IE2 proteins are mutagenic and mediate "hit-and-run" oncogenic transformation in cooperation with the adenovirus E1A proteins | Q36085322 | ||
| In vitro cellular tropism of human B-lymphotropic virus (human herpesvirus-6). | Q36354976 | ||
| Infection of gamma/delta T lymphocytes by human herpesvirus 6: transcriptional induction of CD4 and susceptibility to HIV infection | Q36364690 | ||
| Long-term persistence of cytomegalovirus genome in cultured human cells of prostatic origin | Q36541283 | ||
| Human cytomegalovirus elevates levels of the cellular protein p53 in infected fibroblasts | Q36637901 | ||
| Identification and mapping of dimerization and DNA-binding domains in the C terminus of the IE2 regulatory protein of human cytomegalovirus | Q36653844 | ||
| p53 domains: structure, oligomerization, and transformation | Q36662699 | ||
| Human cytomegalovirus ie2 negatively regulates alpha gene expression via a short target sequence near the transcription start site | Q36680389 | ||
| A cis-acting element in the major immediate-early (IE) promoter of human cytomegalovirus is required for negative regulation by IE2 | Q36680417 | ||
| Potential role of human cytomegalovirus and p53 interaction in coronary restenosis | Q72041267 | ||
| The domain of p53 required for binding HPV 16 E6 is separable from the degradation domain | Q72520479 | ||
| Cytomegalovirus and Kaposi's sarcoma in young homosexual men | Q72528586 | ||
| Cytomegalovirus/herpesvirus and carotid atherosclerosis: the ARIC Study | Q72774085 | ||
| Mutations of the human cytomegalovirus immediate-early 2 protein defines regions and amino acid motifs important in transactivation of transcription from the HIV-1 LTR promoter | Q72847572 | ||
| Humoral- and cell-mediated immune responses to herpesvirus antigens in patients with cervical carcinoma☆☆☆ | Q72859193 | ||
| Kaposi's sarcoma. IV. Detection of CMV DNA, CMV RNA and CMNA in tumor biopsies | Q72915153 | ||
| Kaposi's sarcoma following chemotherapy for testicular cancer in a homosexual man: demonstration of cytomegalovirus RNA in sarcoma cells | Q72958946 | ||
| The p53 activation domain binds the TATA box-binding polypeptide in Holo-TFIID, and a neighboring p53 domain inhibits transcription | Q36685220 | ||
| Transactivation of the cytomegalovirus ICP36 gene promoter requires the alpha gene product TRS1 in addition to IE1 and IE2 | Q36690662 | ||
| Identification and characterization of a human herpesvirus 6 gene segment that trans activates the human immunodeficiency virus type 1 promoter | Q36692142 | ||
| Inhibition of DNA replication factor RPA by p53. | Q36768122 | ||
| Tumor progression mediated by two cooperating DNA segments of human cytomegalovirus | Q36780366 | ||
| Human cytomegalovirus ie1 transactivates the alpha promoter-enhancer via an 18-base-pair repeat element. | Q36781988 | ||
| The IE2 gene products of human cytomegalovirus specifically down-regulate expression from the major immediate-early promoter through a target sequence located near the cap site | Q36796246 | ||
| Identification of a transactivating function mapping to the putative immediate-early locus of human herpesvirus 6 | Q36798152 | ||
| Human herpesvirus 6 is closely related to human cytomegalovirus. | Q36799320 | ||
| Transactivation of a human cytomegalovirus early promoter by gene products from the immediate-early gene IE2 and augmentation by IE1: mutational analysis of the viral proteins | Q36803147 | ||
| Promoter-specific trans activation and repression by human cytomegalovirus immediate-early proteins involves common and unique protein domains | Q36803353 | ||
| Human cytomegalovirus immediate-early two protein region involved in negative regulation of the major immediate-early promoter | Q36811230 | ||
| Regulated expression of early and late RNAs and proteins from the human cytomegalovirus immediate-early gene region | Q36828401 | ||
| The human cytomegalovirus mtrII colinear region in strain Tanaka is transformation defective. | Q36828941 | ||
| Multiple spliced and unspliced transcripts from human cytomegalovirus immediate-early region 2 and evidence for a common initiation site within immediate-early region 1. | Q36853873 | ||
| trans-activation and autoregulation of gene expression by the immediate-early region 2 gene products of human cytomegalovirus | Q36865895 | ||
| p53 cellular tumor antigen: analysis of mRNA levels in normal adult tissues, embryos, and tumors | Q36895398 | ||
| Structure of the transforming region of human cytomegalovirus AD169. | Q36910762 | ||
| Structural analysis of the major immediate early gene of human cytomegalovirus | Q36911017 | ||
| Post-Translational Regulation of the 54K Cellular Tumor Antigen in Normal and Transformed Cells | Q36966578 | ||
| Human herpesvirus 6 DNA in peripheral blood cells and saliva from immunocompetent individuals | Q37068178 | ||
| Wild-type p53 is a cell cycle checkpoint determinant following irradiation | Q37152060 | ||
| Direct interaction between adenovirus E1A protein and the TATA box binding transcription factor IID | Q37531197 | ||
| Neoplastic transformation by a cloned human cytomegalovirus DNA fragment uniquely homologous to one of the transforming regions of herpes simplex virus type 2 | Q37615632 | ||
| Wild-type p53 can down-modulate the activity of various promoters | Q37617210 | ||
| Structural aspects of the p53 protein in relation to gene evolution | Q37856166 | ||
| Viral T-antigen interactions with cellular proto-oncogene and anti-oncogene products | Q37872393 | ||
| Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. | Q37879797 | ||
| The cyclin E promoter is activated by human cytomegalovirus 86-kDa immediate early protein | Q38334420 | ||
| Frequent presence of a novel herpesvirus genome in lesions of human immunodeficiency virus-negative Kaposi's sarcoma | Q38888677 | ||
| Productive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6. | Q39195127 | ||
| Human B-lymphotropic virus (human herpesvirus-6). | Q39279861 | ||
| Lymphocyte Reactivity against Virally Transformed Cells in Patients with Urologic Cancer | Q39458577 | ||
| Cytomegalovirus D.N.A. and adenocarcinoma of the colon: Evidence for latent viral infection | Q39485494 | ||
| Human cytomegalovirus IE1 and IE2 proteins block apoptosis | Q39872769 | ||
| Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells | Q39877852 | ||
| Association of human papillomavirus types 16 and 18 E6 proteins with p53. | Q43701619 | ||
| Complement-fixation antibodies to adenovirus-associated viruses, cytomegaloviruses and herpes simplex viruses in patients with tumors and in control individuals | Q43752403 | ||
| Cytomegalovirus retinitis and acquired immunodeficiency syndrome | Q43761529 | ||
| Meningo-encephalitis associated with HHV-6 related exanthem subitum | Q44662077 | ||
| Human herpesvirus 6 and exanthem subitum | Q44758248 | ||
| Fatal fulminant hepatitis in an infant with human herpesvirus-6 infection | Q44779958 | ||
| Demonstration of cytomegalovirus in semen | Q44865432 | ||
| Human herpesvirus-6 in human lymphomas: identification of specific sequences in Hodgkin's lymphomas by polymerase chain reaction | Q45006318 | ||
| Cervical carcinoma: Detection of herpes simplex virus RNA in cells undergoing neoplastic change | Q45803424 | ||
| Human cytomegalovirus and herpes simplex type 2 virus in normal and adenocarcinomatous prostate glands | Q45804849 | ||
| Occurrence of herpes- and adenovirus antibodies in patients with carcinoma of the cervix uteri. Measurement of antibodies to herpesvirus hominis (types 1 and 2), cytomegalovirus, EB-virus, and adenovirus | Q45820522 | ||
| Detection of human B-lymphotropic virus (human herpesvirus 6) sequences in B cell lymphoma tissues of three patients | Q45832982 | ||
| Genomic analysis of the human B-lymphotropic virus (HBLV). | Q45836010 | ||
| Analysis of human KS biopsies and cloned cell lines for cytomegalovirus, HIV-1, and other selected DNA virus sequences | Q45846090 | ||
| The spectrum of clinical and laboratory findings resulting from human herpesvirus-6 (HHV-6) in patients with mononucleosis-like illnesses not resulting from Epstein-Barr virus or cytomegalovirus | Q45851408 | ||
| Cellular oncogene activation by human cytomegalovirus Lack of correlation with virus infectivity and immediate early gene expression | Q45859711 | ||
| Frequent double infection with Epstein-Barr virus and human herpesvirus-6 in patients with acute infectious mononucleosis | Q45862758 | ||
| Prevalence of Cytomegalovirus Infection in Homosexual Men | Q46032258 | ||
| Adenovirus E1A activation domain binds the basic repeat in the TATA box transcription factor | Q46050449 | ||
| Sequence of the short unique region, short repeats, and part of the long repeats of human cytomegalovirus | Q48356320 | ||
| Adenovirus E1a prevents the retinoblastoma gene product from complexing with a cellular transcription factor | Q52480364 | ||
| p53 domains: identification and characterization of two autonomous DNA-binding regions. | Q52544476 | ||
| Transcriptional activation by p53 correlates with suppression of growth but not transformation. | Q53468212 | ||
| Modulation of MHC antigen expression by viruses and oncogenes | Q53495242 | ||
| Cytomegalovirus infection and viral-induced transformation of human endothelial cells. | Q53522102 | ||
| Cytomegalovirus and carcinogenesis | Q53553430 | ||
| Kaposi's sarcoma and its relationship to cytomegalovirus (CMNV). III. CMV DNA and CMV early antigens in Kaposi's sarcoma. | Q53959716 | ||
| Breast Milk and the Risk of Cytomegalovirus Infection | Q56431619 | ||
| Epstein–Barr Virus in Burkitt's Lymphoma and Nasopharyngeal Carcinoma: EBV DNA in Biopsies of Burkitt Tumours and Anaplastic Carcinomas of the Nasopharynx | Q56689988 | ||
| Binding of general transcription factor TFIIB to an acidic activating region | Q59058683 | ||
| Direct and selective binding of an acidic transcriptional activation domain to the TATA-box factor TFIID | Q59070657 | ||
| Cytomegalovirus DNA in arterial walls of patients with atherosclerosis | Q63983747 | ||
| Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells | Q64381309 | ||
| Alterations in biological properties of different lines of cytomegalorivus-transformed human embryo lung cells following in vitro cultivation | Q66850157 | ||
| Presence of antibodies to human cytomegalovirus in patients with different forms of cancer and in other categories of subjects | Q67240355 | ||
| Lack of Association of Cytomegalovirus Antibody Level with Carcinoma of the Uterine Cervix | Q67245499 | ||
| Infectious Diseases Society of America and Centers for Disease Control: Summary of a Workshop on Surveillance for Congenital Cytomegalovirus Disease | Q68238555 | ||
| Interstitial pneumonitis associated with human herpesvirus-6 infection after marrow transplantation | Q68307767 | ||
| Oncogenic potential of human herpesvirus-6 DNA | Q68480867 | ||
| Identification of human herpesvirus 6-specific DNA sequences in two patients with non-Hodgkin's lymphoma | Q68491462 | ||
| Cytomegalovirus antibody in patients with carcinoma of the uterine cervix | Q68630700 | ||
| Malignant transformation of hamster embryo fibroblasts following exposure to ultraviolet-irradiated human cytomegalovirus | Q68666577 | ||
| Identification of human herpesvirus-6 as a causal agent for exanthem subitum | Q69917877 | ||
| Detection of sequences that hybridize to human cytomegalovirus DNA in cervical neoplastic tissue | Q69919578 | ||
| Clinical and serological features of human herpesvirus-6 infection in three adults | Q69924845 | ||
| Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome | Q70148540 | ||
| Widespread presence of histologically occult cytomegalovirus | Q70213149 | ||
| Herpesvirus Infections in the Acquired Immune Deficiency Syndrome | Q70214424 | ||
| Absence of cytomegalovirus DNA from adenocarcinoma of the colon | Q70796602 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Cytomegalovirus | Q6946 |
| Human herpesvirus 6 | Q6974 | ||
| P304 | page(s) | 367-382 | |
| P577 | publication date | 1999-07-01 | |
| P1433 | published in | Clinical Microbiology Reviews | Q5133777 |
| P1476 | title | Human cytomegalovirus and human herpesvirus 6 genes that transform and transactivate | |
| P478 | volume | 12 |
| Q43139388 | Analysis of colorectal cancers for human cytomegalovirus presence. |
| Q37406553 | Congenital cytomegalovirus infection: molecular mechanisms mediating viral pathogenesis |
| Q24632103 | Consensus on the role of human cytomegalovirus in glioblastoma |
| Q36318051 | Cytomegalovirus occurrence in chronic periodontitis and in carcinoma of the cervix: an exploratory study |
| Q64101460 | DR7 encoded by human herpesvirus 6 promotes glioma development and progression |
| Q34402501 | Detection of human cytomegalovirus in different histological types of gliomas |
| Q38956037 | Detection of human herpesvirus-6 in adult central nervous system tumors: predominance of early and late viral antigens in glial tumors |
| Q34872837 | Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities |
| Q24798984 | Epstein-Barr virus reactivation after superinfection of the BJAB-B1 and P3HR-1 cell lines with cytomegalovirus |
| Q38793250 | Expression of Oncogenic Alleles Induces Multiple Blocks to Human Cytomegalovirus Infection |
| Q37113833 | Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10) |
| Q34683482 | Human cytomegalovirus immediate early proteins and cell growth control |
| Q35016503 | Human cytomegalovirus-encoded chemokine receptor US28 promotes tumorigenesis. |
| Q42445472 | Human herpes viruses in non-melanoma skin cancers. |
| Q36499722 | Identification of novel viral interleukin-10 isoforms of human cytomegalovirus AD169 |
| Q34294353 | Inhibition of cytomegalovirus immediate early gene expression: a therapeutic option? |
| Q47625469 | Lack of association of cytomegalovirus with human brain tumors. |
| Q48487752 | Lack of association of herpesviruses with brain tumors |
| Q34647659 | Lymphoma cell apoptosis in the liver induced by distant murine cytomegalovirus infection |
| Q24811971 | Modulation of p53 activity by IkappaBalpha: evidence suggesting a common phylogeny between NF-kappaB and p53 transcription factors |
| Q45737366 | Presence of Epstein-Barr virus, cytomegalovirus and human papillomavirus in normal oral mucosa of HIV-infected and renal transplant patients |
| Q43010429 | Role of p53, apoptosis, and cell proliferation in early stage Epstein-Barr virus positive and negative gastric carcinomas |
| Q45225206 | Salivary shedding of Epstein-Barr virus and cytomegalovirus in people infected or not by human immunodeficiency virus 1. |
| Q78549918 | Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer |
| Q34350684 | The Epstein-Barr virus immediate-early protein BZLF1 regulates p53 function through multiple mechanisms |
| Q30412209 | The p53-microRNA-34a axis regulates cellular entry receptors for tumor-associated human herpes viruses |
| Q24632829 | The roles of viruses in brain tumor initiation and oncomodulation |
| Q37357932 | The story of human cytomegalovirus and cancer: increasing evidence and open questions |
| Q37810431 | Tumor viruses and cancer biology: Modulating signaling pathways for therapeutic intervention |
| Q35560251 | β-HHVs and HHV-8 in Lymphoproliferative Disorders. |
Search more.